scholarly journals UPDATE OF CARTITUDE-1: A PHASE 1B/2 STUDY OF JNJ-68284528 (JNJ-4528), A B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED CHIMERIC ANTIGEN RECEPTOR T (CAR-T) CELL THERAPY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM)

2020 ◽  
Vol 42 ◽  
pp. 279-280 ◽  
Author(s):  
J.G. Berdeja ◽  
D. Madduri ◽  
S.Z. Usmani ◽  
I. Singh ◽  
E. Zudaire ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Cell Therapy ◽  
Chimeric Antigen Receptor ◽  
Cell Maturation ◽  
T Cell Therapy ◽  
B Cell Maturation ◽  
Car T Cell Therapy ◽  
Car T ◽  
Phase 1B ◽  
B Cell Maturation Antigen

scholarly journals Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen

2019 ◽  
Vol 10 ◽  
Author(s):  
Marijke Timmers ◽  
Gils Roex ◽  
Yuedi Wang ◽  
Diana Campillo-Davo ◽  
Viggo F. I. Van Tendeloo ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
T Cell ◽  
Cell Therapy ◽  
B Cell ◽  
Chimeric Antigen Receptor ◽  
Antigen Receptor ◽  
Cell Maturation ◽  
T Cell Therapy ◽  
B Cell Maturation ◽  
B Cell Maturation Antigen

scholarly journals B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma

2013 ◽  
Vol 19 (8) ◽  
pp. 2048-2060 ◽  
Author(s):  
Robert O. Carpenter ◽  
Moses O. Evbuomwan ◽  
Stefania Pittaluga ◽  
Jeremy J. Rose ◽  
Mark Raffeld ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
T Cell ◽  
Cell Therapy ◽  
B Cell ◽  
Adoptive T Cell Therapy ◽  
Cell Maturation ◽  
T Cell Therapy ◽  
B Cell Maturation ◽  
Promising Target ◽  
B Cell Maturation Antigen
Sign in / Sign up

Export Citation Format

Share Document